1

Mar, 2017

The European Paediatric Mycology Network (EPMyN): Towards a Better Understanding and Management of Fungal Infections in Children

 

The European Paediatric Mycology Network (EPMyN) was launched in 2014 to create a European platform for research and education in the field of paediatric mycology. The EPMyN aims to address the lack of paediatric specific evidence and knowledge needed to (1) improve the management and outcome of invasive fungal infections in children and neonates and to (2) enhance and develop paediatric antifungal stewardship programmes.

Author: Adilia Warris

Published in: This article is published with open access at Springerlink.com

Read the publication

24

Feb, 2017

Qualitative study of the BREATHER trial (Short Cycle antiretroviral therapy): is it acceptable to young people living with HIV?

 

A qualitative study of the BREATHER (PENTA 16) randomised clinical trial, which compared virological control of Short Cycle Therapy (SCT) (5 days on: 2 days off) with continuous efavirenz (EFV)-based antiretroviral therapy (CT) in children and young people (aged 8–24) living with HIV with viral load <50 c/mL to examine adaptation, acceptability and experience of SCT to inform intervention development.

Author: Bernays S, Paparini S, Seeley J, et al.

Published in: BMJ Open 2017;7:e012934. doi:10.1136/bmjopen-2016- 012934

Read the publication

27

Dec, 2016

Safety of zidovudine/ lamivudine scored tablets in children with HIV infection in Europe and Thailand.

 

Published in: European Journal of Clinical Pharmacology, in press.

Read the publication

20

Nov, 2016

Tuberculosis in HIV-infected children in Europe, Thailand and Brazil: paediatric TB-HIV EuroCoord study

 

Published in: Int J Tuberc Lung Dis 2016, 20:1448-1456.

Read the publication

11

Nov, 2016

Interventions to improve treatment, retention and survival outcomes for adolescents with perinatal HIV-1 in high- and middle-income countries: Moving on up.

 

Authors: Judd A, Sohn A, Collins J.

Published in: Current Opinion in HIV and AIDS 2016; 11(5): 477-486

Read the publication

8

Nov, 2016

Prevalence and effect of pre-treatment drug resistance on the virological response to antiretroviral treatment initiated in HIV-infected children – a EuroCoord-CHAIN-EPPICC joint project.

 

Published in: BMC Infectious Diseases, in press.

Read the publication

14

Sep, 2016

Higher rates of triple class virologic failure in perinatally HIV-infected teenagers compared to heterosexually infected young adults in Europe. 

 

Published in: HIV Medicine, in press.

Read the publication

1

Jul, 2016

I was like, oh my God, what happens if it doesn’t work’?: young people living with HIV, clinical trial participation, and the truth economy accepted for presentation at BSA Medical Sociology Conference

 

Author: Bernays S, Seeley J, Paparini S, Rhodes T

Published: BSA Medical Sociology Conference, York, 9-11 September 2015 (Paper ID No: W0012148)

Read the publication

24

Jun, 2016

Optimal timing of antiretroviral treatment initiation in HIV-positive children and adolescents – a multiregion analysis from Southern Africa, West Africa, and Europe.

 

Authors: Schomaker M, Leroy V, Wolfs T, Technau KG, Renner L, Judd A, et al. on behalf of the IeDEA West and Southern Africa regional collaborations and COHERE in EuroCoord.

Published in: International Journal of Epidemiology – in press.

Read the publication

1

Jun, 2016

Weekends-off efavirenz-based antiretroviral therapy in HIV-infected children, adolescents, and young adults (BREATHER): a randomised, open-label, non-inferiority, phase 2/3 trial

 

Author: The BREATHER (PENTA 16) Trial Group

 

Read the publication